 |
Mesna |
|---|---|
| Trade Name | Mesnex |
| Orphan Indication | For use as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis |
| USA Market Approval | USA |
| USA Designation Date | 1985-11-14 00:00:00 |
| Sponsor | Degussa Corporation;65 Challenger Road;Ridgefield Park, New Jersey, 07660 |
